Print Page | Sign In | Join FSN
2019 FSN Business Partners
Share |

 

Platinum Partner

 

Amgen

Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering , developing, manufacturing and delivering innovative human therapeutics.  A biotechnology pioneer since 1980, Amgen has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential. 


 

Gold Partner

 

Mallinckrodt Pharmaceuticals


 Silver Partner

 

MedPro & Danna-Gracey

 

 

 

 

Bronze Partners

 
   

 

Alexion, CM Group

 

 

     
    AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialization of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Oncology, Cardiovascular, Renal & Metabolism and Respiratory. AstraZeneca’s innovative medicines are used by millions of patients worldwide.

     

 

Davita, Inc is a leading provider of kidney care in  the United States, delivering dialysis services to patients with chronic kidney failure and end stage renal disease. DaVita operates ~2,500 outpatient dialysis centers located in the United States serving approximately 200K patients, and operates in 12 countries worldwide. DaVita—which is Italian for "giving life"—has more than 70,800 teammates (employees) working to provide superior patient care and exemplify the company’s Core Values.

     
   

Fresenius Kidney Care North/South Florida Region

 

     
    N'Sync Consulting brings together a unique blend of expertise in the field of End Stage Renal Disease management. Our principals bring over 100 years’ experience in all aspects across the ESRD spectrum. N’Sync Consulting provides comprehensive consulting, management, JV and dialysis billing services to the Renal Disease Industry.
     
    OPKO Renal is developing proprietary products to treat secondary hyperparathyroidism (SHPT) associated with chronic kidney disease and vitamin D insufficiency. These products are designed to treat patients with Stage 3, 4 or 5 CKD, but also have potential application to other indications including MBD, such as renal osteodystrophy and osteoporosis.
     
    Sanofi Genzyme

 

FLORIDA SOCIETY OF NEPHROLOGY
1215 E. Robinson Street, Orlando, FL 32801
Phone: 813-909-0450  |  Fax: 813-949-8994